Wikidata

(Q61865052)

English

A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors

clinical trial

In more languages

Statements

title
A Phase I Study of ABT-888, an Oral Inhibitor of Poly(ADP-Ribose) Polymerase and Temozolomide in Children With Recurrent/Refractory CNS Tumors (English)
0 references
medical condition
astrocytoma
0 references
ependymoma
0 references
medulloblastoma
0 references
start time
22 September 2009
0 references
number of participants
9
0 references
research intervention
temozolomide
0 references
dacarbazine
0 references
veliparib
0 references
PARP inhibitor
0 references
maximum age
21 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61865052&oldid=2109095828"